INBP

distress 0/10 · well-funded / low risk

$0.160%today-58% from 52w high

ir.ibiopharma.com153 employeesFounded 1980Hillside, NJPackaged Foods

Revenue

pre-revenue

Liquidity

$6M

Runway

—

Shares 1y

Price & events

-55.6% over 6M

CatalystRating changeDilutionFinancingdashed = today

+0.0%

-15.8%

-38.5%

-55.6%

-42.9%

-20.0%

-85.0%

-77.5%

All

Overview

Market Cap: $4.97M
Volume: 1.00K
52 Week Range: $0.16 – $0.38
Total Shares: 31.06M
Float Shares: 7.22M
% Held by Insiders: 68.43%
% Held by Institutions: 0.06%
RVOL: 0.24x
Beta: 0.35

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 31,059,610 · 0 offerings/1y · 0 PIPEs

2026-07-028-Kmaterial_agreement
2026-02-188-Kmaterial_agreement
2025-04-218-Kmaterial_agreement

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified